Sustained spike-specific IgG antibodies following CoronaVac (Sinovac) vaccination in sub-Saharan Africa, but increased breakthrough infections in baseline spike-naive individuals. (2023)
Attributed to:
Immunomodulation and Vaccines
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3389/fimmu.2023.1255676
PubMed Identifier: 38098482
Publication URI: http://europepmc.org/abstract/MED/38098482
Type: Journal Article/Review
Volume: 14
Parent Publication: Frontiers in immunology
ISSN: 1664-3224